Analytical characterization of coformulated antibodies as combination therapy

When two therapeutic agents are combined in a single formulation, i.e., coformulated, the quality and safety of the individual agents must be preserved. Here we describe an approach to evaluate the quality attributes of two individual monoclonal antibodies (mAbs), designated mAb-A and mAb-B, in cofo...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jun Kim, Yoen Joo Kim, Mingyan Cao, Niluka De Mel, Kenneth Miller, Jared S. Bee, Jihong Wang, Xiangyang Wang, Methal Albarghouthi
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis Group 2020-01-01
Collection:mAbs
Sujets:
Quality attributes
monoclonal antibody
combination therapy
coformulated antibodies
hydrophobic interaction chromatography
higher-order structure
Accès en ligne:https://www.tandfonline.com/doi/10.1080/19420862.2020.1738691
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires